Adverum Biotechnologies Stock In The News

ADVM Stock  USD 4.61  0.11  2.44%   
Our overall analysis of Adverum Biotechnologies' news coverage and content from conventional and social sources shows investors' bearish mood towards Adverum Biotechnologies. The specific impact of Adverum Biotechnologies news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Adverum Biotechnologies' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Adverum Biotechnologies headlines in addition to utilizing other, more conventional financial analysis modules. Check out Adverum Biotechnologies Backtesting and Adverum Biotechnologies Hype Analysis.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.

Adverum Biotechnologies Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
https://www.globenewswire.com/news-release/2025/03/03/3036018/32452/en/Adverum-Biotechnologies-Initiates-ARTEMIS-Phase-3-Study-Evaluating-Ixo-vec-for-Wet-AMD.html
 Bullish
Macroaxis News: globenewswire.com
Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference
https://www.globenewswire.com/news-release/2025/02/25/3031822/32452/en/Adverum-Biotechnologies-to-Participate-in-the-Cowen-45th-Annual-Health-Care-Conference.html
 Bullish
Yahoo News
Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks
https://finance.yahoo.com/news/wall-street-analysts-just-trimmed-115247780.html
 Bullish
Yahoo News
Stocks on the Launchpad: The Next 3 Market Sensations
https://finance.yahoo.com/news/stocks-launchpad-next-3-market-111000240.html
 Bullish
Yahoo News
Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer
https://finance.yahoo.com/news/adverum-biotechnologies-appoints-romuald-corbau-130000462.html
 Neutral
Yahoo News
Here's Why You Should Invest in Adverum (ADVM) Stock Now
https://finance.yahoo.com/news/heres-why-invest-adverum-advm-132700101.html
 Bullish
Yahoo News
Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society
https://finance.yahoo.com/news/adverum-biotechnologies-present-luna-preliminary-210500759.html
 Neutral
Macroaxis News: globenewswire.com
Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference
https://www.globenewswire.com/news-release/2023/11/28/2787352/32452/en/Adverum-Biotechnologies-to-Participate-in-the-Evercore-ISI-6th-Annual-HealthCONx-Conference.html
 Bullish
Yahoo News
Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference
https://finance.yahoo.com/news/adverum-biotechnologies-participate-evercore-isi-210500181.html
 Bullish
Macroaxis News: globenewswire.com
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
https://www.globenewswire.com/news-release/2023/11/09/2777800/32452/en/Adverum-Biotechnologies-Reports-Third-Quarter-2023-Financial-Results-and-Pipeline-Highlights.html
 Neutral

Adverum Biotechnologies Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Adverum and other traded companies coverage with news coverage. We help investors stay connected with Adverum headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Adverum Stock performance. Please note that trading solely based on the Adverum Biotechnologies hype is not for everyone as timely availability and quick action are needed to avoid losses.
Adverum Biotechnologies' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Adverum Biotechnologies investors visualize upcoming and past events in order to time the market based on Adverum Biotechnologies noise-free hype analysis.
Adverum Biotechnologies stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Adverum earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Adverum Biotechnologies that are available to investors today. That information is available publicly through Adverum media outlets and privately through word of mouth or via Adverum internal channels. However, regardless of the origin, that massive amount of Adverum data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Adverum Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Adverum Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Adverum Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Adverum Biotechnologies alpha.

Adverum Largest EPS Surprises

Earnings surprises can significantly impact Adverum Biotechnologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-11-08
2017-09-30-0.29-0.32-0.0310 
2020-05-28
2020-03-31-0.27-0.31-0.0414 
2019-05-08
2019-03-31-0.27-0.230.0414 
2019-03-06
2018-12-31-0.29-0.250.0413 
2018-11-08
2018-09-30-0.3-0.260.0413 
2022-11-10
2022-09-30-0.34-0.4-0.0617 
View All Earnings Estimates

Adverum Biotechnologies Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Adverum Biotechnologies Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
4th of March 2025
Oppenheimer maintains Outperform on Adverum stock, 32 target - Investing.com
at news.google.com 
Macroaxis News: globenewswire.com
28th of February 2025
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635
at globenewswire.com 
news
25th of February 2025
How Is Adverum Biotechnologies Positioned in the Gene Therapy Sector
at kalkinemedia.com 
Gurufocus Stories at Macroaxis
5th of February 2025
Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Scie...
at gurufocus.com 
Google News at Macroaxis
15th of January 2025
Adverum Biotechnologies stock hits 52-week low at 4.4 By Investing.com - Investing.com Nig...
at news.google.com 
Google News at Macroaxis
23rd of December 2024
Adverum Biotechnologies stock hits 52-week low at 4.61 - Investing.com
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adverum Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adverum Biotechnologies' short interest history, or implied volatility extrapolated from Adverum Biotechnologies options trading.
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Adverum Biotechnologies Backtesting and Adverum Biotechnologies Hype Analysis.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.95)
Revenue Per Share
0.059
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.30)
Return On Equity
(0.76)
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.